Embecta Executive and Leadership Team

Devdatt Kurdikar, the President & Chief Executive Officer & Chair of the Board at Embecta, directs the company's overarching strategy and governance. Kurdikar guides the organization's mission to manufacture medical equipment essential for diabetes treatment, ensuring alignment with market needs and patient well-being. This leadership role involves setting the strategic vision for product development and market expansion, particularly within the critical diabetes care sector. By fostering innovation and operational excellence, Kurdikar drives the company's growth and its commitment to improving the lives of individuals managing diabetes. The President & Chief Executive Officer & Chair of the Board ensures robust financial performance and sustainable business practices across all operational facets. Devdatt Kurdikar's executive oversight extends to cultivating key stakeholder relationships and championing the company's position in the global medical technology landscape.

Jacob Elguicze, the Senior Vice President, Chief Financial Officer at Embecta, oversees all financial operations and strategic fiscal planning for the company's medical equipment manufacturing business. Elguicze manages financial reporting, budgeting, forecasting, and investment strategies, ensuring the fiscal health and sustainability of Embecta's operations in diabetes care. This critical role involves optimizing financial performance, managing risk, and allocating resources effectively to support product development and market expansion initiatives. By providing insightful financial analysis, the Senior Vice President, Chief Financial Officer guides executive decision-making and strengthens the company's financial resilience. Jacob Elguicze's leadership ensures that Embecta maintains robust financial controls and pursues strategic growth opportunities that align with its mission to improve diabetes management worldwide.

Jenna Sharpe, the Chief Marketing Officer at Embecta, architects and executes comprehensive marketing strategies to advance the company's diabetes treatment solutions. Sharpe oversees all brand initiatives, market analysis, and customer engagement programs designed to enhance Embecta's presence in the medical equipment manufacturing sector. This role focuses on communicating the value of Embecta's specialized products to healthcare providers and patients, driving market penetration and brand loyalty. By identifying emerging market trends and consumer needs, the Chief Marketing Officer ensures that Embecta's offerings remain competitive and responsive to the evolving landscape of diabetes care. Jenna Sharpe's leadership cultivates a deep understanding of customer requirements, translating insights into actionable marketing campaigns that support the company's growth objectives and its mission to improve diabetes management globally.

Leisha Ayres, the Head Chief Information Officer, Shared Services at Embecta, directs the strategic implementation and management of information technology infrastructure and shared services. Ayres ensures the seamless operation of critical IT systems that support Embecta's manufacturing of diabetes treatment equipment, optimizing efficiency and data security. This leadership position involves overseeing technology roadmaps, digital transformation initiatives, and the integration of advanced IT solutions across the organization. By driving technological innovation, the Head Chief Information Officer, Shared Services enhances operational capabilities and supports the company's commitment to delivering high-quality medical devices. Leisha Ayres's focus on robust IT governance and scalable infrastructure is vital for maintaining Embecta's competitive edge and ensuring reliable service delivery to its global customer base.

Michael Lorusso, the Head Chief Information Officer, Shared Services at Embecta, spearheads the strategic direction and operational execution of information technology services and shared functions. Lorusso ensures that Embecta's technological infrastructure robustly supports the manufacturing of essential diabetes treatment equipment, driving efficiency and data integrity. This executive position involves leading digital initiatives, enhancing cybersecurity measures, and optimizing IT resource allocation to meet the company's evolving business needs. By championing technological advancements, the Head Chief Information Officer, Shared Services empowers Embecta to maintain its leadership in medical device innovation. Michael Lorusso's commitment to operational excellence in IT is fundamental to the company's ability to deliver reliable and advanced solutions for diabetes care globally.

Jean Casner, the Senior Vice President and Chief Human Resources Officer at Embecta, directs all human capital strategies and organizational development initiatives for the company's diabetes care equipment manufacturing operations. Casner oversees talent acquisition, employee relations, compensation and benefits, and leadership development programs, fostering a high-performance culture. This role is pivotal in ensuring Embecta attracts, retains, and develops the skilled workforce necessary to innovate and produce critical medical devices. By championing employee engagement and organizational effectiveness, the Senior Vice President and Chief Human Resources Officer supports Embecta's mission to improve patient outcomes. Jean Casner's strategic approach to human resources is integral to building a resilient and motivated team dedicated to advancing diabetes treatment solutions worldwide.

Henry Anhalt, the Global Chief Medical Officer, Head Medical, Clinical Scientific Affairs at Embecta, provides critical medical and scientific leadership for the company's diabetes treatment solutions. Anhalt guides the clinical strategy, scientific research, and medical affairs functions, ensuring Embecta's products meet the highest standards of patient safety and efficacy. This executive position involves translating clinical insights into product development and advocating for evidence-based practices in diabetes management. By fostering strong relationships with the medical community and regulatory bodies, the Global Chief Medical Officer, Head Medical, Clinical Scientific Affairs ensures Embecta remains at the forefront of medical innovation. Henry Anhalt's expertise is essential for driving the company's mission to enhance the lives of individuals managing diabetes through advanced medical equipment.